Spotting a gap: recent research shows gay, bisexual and transgender women are less likely to get recommended breast and cervical cancer screening, and experts say targeted fixes , from better clinician training to inclusive intake forms , could help close the divide.

Essential Takeaways

  • Lower screening rates: Gay and bisexual women had modestly lower uptake of breast and cervical screening; transgender women faced the steepest shortfall.
  • Big disparity for trans women: Transgender women were about 76% less likely to receive breast cancer screening and 42% less likely to get cervical screening compared with cisgender women.
  • Data source: Findings come from a large analysis of the Behavioural Risk Factor Surveillance System (2018–2022) covering 663,924 respondents.
  • No higher cancer prevalence: The study did not find significant differences in cancer prevalence by sexual orientation or gender identity.
  • Practical fixes suggested: Authors recommend gender-affirming environments, routine SOGI data collection, clinician education and nonheteronormative communications to boost screening.

Why these figures matter now , a striking shortfall in routine care

The headline numbers hit hard because screening is one of the clearest ways to catch cancer early, when treatment is more likely to succeed. According to the study published in Cancer, the gap is especially large for transgender women, a detail that feels both alarming and avoidable. The research team used the Behavioural Risk Factor Surveillance System to compare adherence to U.S. Preventive Services Task Force screening guidelines, which gives the analysis scale and policy relevance.

This isn’t just an academic stat: lower screening translates into missed opportunities for early detection. So the finding that transgender women are substantially less likely to be screened points to both access problems and real-world consequences for outcomes.

What’s driving lower screening among sexual- and gender-minority women?

Several forces are at work. Past studies and commentary from groups such as the American Cancer Society and ASCO point to structural barriers , lack of insurance, past negative experiences with clinicians, and clinic environments that feel unwelcoming. There’s also simple practical friction: intake forms and appointment reminders that assume heterosexuality or cisgender identity can make people feel unseen.

Clinician training matters too. When front-line staff and doctors don’t use inclusive language or understand organ-specific screening needs for transgender patients, conversations about risk and tests can fall through the cracks. The study authors call for better training and policy fixes to remove those frictions.

What clinics and systems can do today , practical, immediate steps

Health systems don’t need a policy revolution to make things better. Small, concrete moves include updating intake forms to collect sexual orientation and gender identity (SOGI) respectfully, training staff in gender-affirming communication, and using neutral pronouns and language in reminders. According to the researchers, routine SOGI collection in national surveys would also help monitor progress.

Clinics should also make clear which services they provide and who they’re for , visible signage, inclusive imagery and staff who use nonheteronormative language can all reduce anxiety. For screening logistics, offering same-day or walk-in appointments and clear explanations about what a test involves helps people who’ve avoided care because they worried about discomfort or judgement.

How patients and advocates can push for better access

If you’re an individual patient, bring SOGI issues into the conversation: ask how your provider handles gender-affirming care and whether they offer the screening that fits your anatomy and risk profile. Community groups and advocates can press local clinics and health systems to adopt inclusive intake forms and staff training, and to publicise that change so it reaches those who need it.

Policy-wise, researchers urge routine SOGI data collection at national level so disparities can be tracked and addressed. Organisations such as the American Cancer Society have long highlighted health disparities research, and expanding those efforts could turn findings into targeted programmes.

Looking ahead , bridging a preventable gap

The research makes a clear case: disparities aren’t about biology alone, they’re about systems and relationships. Improving training, data collection and the patient experience could raise screening rates for sexual- and gender-minority women and, in time, reduce preventable cancer harms. It’s a fix that’s practical, measurable and overdue.

It’s a small change in practice that could make every screening feel safer and more accessible.

Source Reference Map

Story idea inspired by: [1]

Sources by paragraph: